RE:RE:RE:Claris on CRH: UndervaluedI've heard that analyst before on another company's conference call and he appeared detail orientated in his questioning.
Another specialty pharma that has been on fire is TH.to. A lot may be discounted already for the coming quarter given the run it has had but they release results tomorrow.